Recombinant sars-cov-2 spike-eiwit xbb.1.5 variant
mNEXSPIKE dispersie voor injectie in een voorgevulde spuit COVID-19-mRNA-vaccin
In other countries
The same active substances on other registers, the same brand first.
Authorised centrally in the EU
This national listing belongs to a medicine the European Commission authorised for the whole EU.
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
College ter Beoordeling van Geneesmiddelen
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.